8-Hydroxyquinolylnitrones as multifunctional ligands for the therapy of neurodegenerative diseases
Acta Pharmaceutica Sinica B · 2023-05 · 13 (5) · 2152-2175
DOI: 10.1016/j.apsb.2023.01.013 ↗Kurz gefasst
Fachartikel in der Zeitschrift Acta Pharmaceutica Sinica B, 2023-05. Verfasst von Damijan Knez und 22 weiteren Autor:innen. Beteiligte Einrichtung: University of Ljubljana, Faculty of Pharmacy, Ljubljana 1000, Slovenia. Die Arbeit wurde bisher 45-mal zitiert (Crossref) und nennt 104 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: Ministero dell’Istruzione, dell’Università e della Ricerca, Javna Agencija za Raziskovalno Dejavnost RS, Università degli Studi di Pavia.
Abstract (Originalsprache)
We describe the development of quinolylnitrones (QNs) as multifunctional ligands inhibiting cholinesterases (ChEs: acetylcholinesterase and butyrylcholinesterase-hBChE) and monoamine oxidases (hMAO-A/B) for the therapy of neurodegenerative diseases. We identified QN 19, a simple, low molecular weight nitrone, that is readily synthesized from commercially available 8-hydroxyquinoline-2-carbaldehyde. Quinolylnitrone 19 has no typical pharmacophoric element to suggest ChE or MAO inhibition, yet unexpectedly showed potent inhibition of hBChE (IC50 = 1.06 ± 0.31 nmol/L) and hMAO-B (IC50 = 4.46 ± 0.18 μmol/L). The crystal structures of 19 with hBChE and hMAO-B provided the structural basis for potent binding, which was further studied by enzyme kinetics. Compound 19 acted as a free radical scavenger and biometal chelator, crossed the blood-brain barrier, was not cytotoxic, and showed neuroprotective properties in a 6-hydroxydopamine cell model of Parkinson's disease. In addition, in vivo studies showed the anti-amnesic effect of 19 in the scopolamine-induced mouse model of AD without adverse effects on motoric function and coordination. Importantly, chronic treatment of double transgenic APPswe-PS1δE9 mice with 19 reduced amyloid plaque load in the hippocampus and cortex of female mice, underscoring the disease-modifying effect of QN 19.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- University of Ljubljana, Faculty of Pharmacy, Ljubljana 1000, Slovenia.
- Laboratory of Medicinal Chemistry (Institute of Organic Chemistry, CSIC); Madrid 28006, Spain.
- Departamento de Química Orgánicay Química Inorgánica, Alcalá de Henares, Madrid 28871, Spain.
- Department of Biology and Biotechnology, University of Pavia, Pavia 27100, Italy.
- Département de Toxicologie et Risques Chimiques, Institut de Recherche Biomédicale des Armées, Paris 91220, France.
- Department of Animal Anatomy and Preclinical Sciences, University Centre of Veterinary Medicine JU-UA, University of Agriculture in Krakow, Krakow 30-059, Poland.
Förderung
- Ministero dell’Istruzione, dell’Università e della Ricerca
- Javna Agencija za Raziskovalno Dejavnost RS
- Università degli Studi di Pavia
- Universidad Camilo José Cela
- Ministère des Armées
- Ministerio de Economía y Competitividad
- Ministerio de Ciencia, Innovación y Universidades
Zitieren
APA
Knez, D., Diez-Iriepa, D., Chioua, M., Gottinger, A., Denic, M., Chantegreil, F., Nachon, F., Brazzolotto, X., Skrzypczak-Wiercioch, A., Meden, A., Pišlar, A., Kos, J., Žakelj, S., Stojan, J., Sałat, K., Serrano, J., Fernández, A. P., Sánchez-García, A., Martínez-Murillo, R., …, & Marco-Contelles, J. (2023). 8-Hydroxyquinolylnitrones as multifunctional ligands for the therapy of neurodegenerative diseases. Acta Pharmaceutica Sinica B, 13(5), 2152-2175. https://doi.org/10.1016/j.apsb.2023.01.013
Vancouver
Knez D, Diez-Iriepa D, Chioua M, Gottinger A, Denic M, Chantegreil F, et al. 8-Hydroxyquinolylnitrones as multifunctional ligands for the therapy of neurodegenerative diseases. Acta Pharmaceutica Sinica B. 2023;13(5):2152-2175. doi:10.1016/j.apsb.2023.01.013
BibTeX
@article{Knez2023,
author = {Knez, Damijan and Diez-Iriepa, Daniel and Chioua, Mourad and Gottinger, Andrea and Denic, Milica and Chantegreil, Fabien and Nachon, Florian and Brazzolotto, Xavier and Skrzypczak-Wiercioch, Anna and Meden, Anže and Pišlar, Anja and Kos, Janko and Žakelj, Simon and Stojan, Jure and Sałat, Kinga and Serrano, Julia and Fernández, Ana Patricia and Sánchez-García, Aitana and Martínez-Murillo, Ricardo and Binda, Claudia and López-Muñoz, Francisco and Gobec, Stanislav and Marco-Contelles, José},
title = {8-Hydroxyquinolylnitrones as multifunctional ligands for the therapy of neurodegenerative diseases},
journal = {Acta Pharmaceutica Sinica B},
year = {2023},
volume = {13},
number = {5},
pages = {2152--2175},
doi = {10.1016/j.apsb.2023.01.013}
}
EUVIMED